[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"AtriCure, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":138},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,45,68,89,114],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100592157","boxx-noaf-clinical-trial-100592157",false,"NCT06989775","BoxX-NoAF Clinical Trial","EnCompass Clamp and the AtriClip in Box Lesion and Left Atrial Appendage EXclusion Procedure for the Prevention of New Onset of Atrial Fibrillation","Inclusion Criteria:\n\n* Planned and clinically indicated for cardiac surgical procedure requiring cardiac bypass and opening of the pericardium\n* Age ≥ 65 years and CHA2DS2-VASc ≥ 3\n\nExclusion Criteria:\n\n* Documented history of atrial fibrillation or atrial flutter anytime prior to the cardiac surgery\n* Prior procedure involving opening the pericardium or entering the pericardial space\n* Patients undergoing off-pump surgery\n* Prior LAA occlusion, exclusion, or removal (surgical or percutaneous)\n* Presence of a permanent pacemaker\n* Infiltrative cardiomyopathies (i.e. amyloidosis)\n* Planned cardiac surgical procedure using non-sternotomy approaches\n* Patients whose planned procedure is a heart transplant or implantation of any long-term ventricular assist devices\n* Presence of ventricular arrhythmia\n* Active endocarditis\n* NYHA Class IV heart failure symptoms\n* Preoperative need for an intra-aortic ballon pump or intravenous inotropes\n* Active systemic infection at the time of cardiac surgery requiring antibiotics\n* Known allergy to Nitinol or nickel sensitivity\n* Known medical condition with expected survival of less than 1 year\n* Other comorbidities that in the Investigator's opinion make the subject unsuitable candidate to complete the protocol required intervention or visits\n* Current enrollment in an investigation or trial or an investigational devices or investigational drug that would interfere with this trial\n* Mental impairment or other psychiatric conditions which may not allow the patient to understand the nature, significance, and scope of the trial.\n* Pregnancy\n* Known severe symptomatic carotid disease",true,"ALL","65 Years",{"count":20,"type":21},960,"ESTIMATED","INTERVENTIONAL",[24],"NA","Post Operative Atrial Fibrillation (POAF) is the most common complication of cardiac surgery. POAF incidence can exceed 50% depending on the patient baseline characteristics and surgery type. Patients with POAF tend to have worse acute and long-term clinical outcomes. BoxX-NoAF is a randomized trial to evaluate if prophylactic ablation and exclusion of the Left Atrial Appendage at the time of other routine cardiac surgery can reduce the incidence of post operative AF and clinical AF during long term follow up in patients who have not yet developed AF but are at risk.",[27,28],"Post Operative Atrial Fibrillation","Atrial Fibrillation, Postoperative",[30,31],"Post operative AF","Clinical AF","RECRUITING","2026-06-26",{"date":35,"type":36},"2026-06-29","ACTUAL",{"date":38,"type":36},"2025-10-24",{"date":40,"type":21},"2029-12",{"name":42,"class":43},"AtriCure, Inc.","INDUSTRY",27,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":52,"maxAge":4,"enrollmentInfo":53,"targetDuration":55,"studyType":56,"phases":4,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":61,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},"100447790","tracking-results-of-ablations-to-combat-af-registry-generation-2-100447790","NCT05111015","Tracking Results of Ablations to Combat AF Registry Generation 2","TRAC-AF","Inclusion Criteria:\n\n1. Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s)\n2. Patient is willing to provide informed consent\n3. Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law\n\nExclusion Criteria:\n\n1\\. Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.","18 Years",{"count":54,"type":21},10000,"10 Years","OBSERVATIONAL","The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and\u002For hybrid ablation, and management of the LAA concomitant to a cardiac ablation.",[59],"Atrial Fibrillation",[59],{"date":35,"type":36},{"date":63,"type":36},"2024-03-11",{"date":65,"type":21},"2040-01",{"name":42,"class":43},29,{"id":69,"slug":70,"hasResults":11,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":17,"minAge":76,"maxAge":4,"enrollmentInfo":77,"targetDuration":79,"studyType":56,"phases":4,"briefSummary":80,"conditions":81,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":83,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":87,"locationsCount":88},"100447788","a-multicenter-patient-registry-on-outcomes-from-cryoanalgesia-of-the-intercostal-nerves-100447788","NCT05110989","A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves","The CryoICE™ Cryoanalgesia Registry for Pain Management in Post-cardiothoracic Surgery Via Cryoablation of the Intercostal Nerves","REDUCE","Inclusion Criteria:\n\n1. Patients whose age is 12 years or above, and are able to give informed consent\u002Fassent specific to state and national law.\n2. Patients have been scheduled by physician(s) to undergo or have undergone cryoablation of the intercostal nerves utilizing at least one AtriCure device or are similar patients treated without the use of cryoablation\n\nExclusion Criteria:\n\n1. Patient is enrolled in a concurrent trial that may impact the treatment offered by the registry devices.\n2. Patient with exclusion criteria required by local governance.\n3. Women of childbearing potential who are, or plan to become, pregnant during the time of the study","12 Years",{"count":78,"type":21},5000,"5 Years","This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operative pain management.",[82],"Post Operative Pain",{"date":35,"type":36},{"date":85,"type":36},"2018-06-29",{"date":65,"type":21},{"name":42,"class":43},11,{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":11,"sex":17,"minAge":52,"maxAge":4,"enrollmentInfo":97,"targetDuration":79,"studyType":56,"phases":4,"briefSummary":99,"conditions":100,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":5},"100585912","cryo-nerve-block-extremity-amputation-registry-for-post-operative-and-phantom-limb-pain-100585912","NCT06908538","Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain","Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain (VANISH)","VANISH","Inclusion Criteria:\n\n* Patients who have or will have an amputation procedure;\n* Patients who are willing and capable of providing informed consent;\n* Patients whose age is 18 years or above, or of legal age to give informed consent specific to state and national law.\n\nExclusion Criteria:\n\n* Women of childbearing potential who are, or plan to become, pregnant during the time of the study;\n* Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.",{"count":98,"type":21},2000,"The goal of this Registry is to see how the device is used when freezing nerves during an amputation procedure.",[101,102,103,104,105,106],"Amputation","Amputation of Lower Limb","Amputation of Upper Limb","Amputation, Limb Loss","Amputation, Traumatic\u002FSurgery","Cryo Analgesia","2026-06-25",{"date":33,"type":36},{"date":110,"type":36},"2025-04-01",{"date":112,"type":21},"2035-04",{"name":42,"class":43},{"id":115,"slug":116,"hasResults":11,"nctId":117,"briefTitle":118,"officialTitle":119,"acronym":4,"eligibilityCriteria":120,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":121,"targetDuration":123,"studyType":56,"phases":4,"briefSummary":124,"conditions":125,"keywords":128,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":131,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":137},"100447530","inappropriate-sinus-tachycardia-registry-100447530","NCT05107635","Inappropriate Sinus Tachycardia Registry","A Multicenter Patient Registry for Outcomes of Inappropriate Sinus Tachycardia and Postural Orthostatic Tachycardia Syndrome Treatment","Inclusion Criteria:\n\n1. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices.\n2. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements\n\nExclusion Criteria:\n\n1. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS.\n2. Subject with exclusion criteria required by FDA or local governance",{"count":122,"type":21},500,"12 Months","The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US\u002FOUS, observational data registry.",[126,127],"Inappropriate Sinus Tachycardia","Postural Tachycardia Syndrome",[126,129,130],"Postural Tachycardia Syndrome;","Sinus Node Sparing Hybrid Procedure",{"date":33,"type":36},{"date":133,"type":36},"2022-03-01",{"date":135,"type":21},"2027-01",{"name":42,"class":43},12,""]